Insight journal - Company

Gilead Sciences: M&A activity 2005-2013

Posted on 16 July 2013

Tags: ,

Gilead Sciences has also announced 9 M&A deals since 2005, with the lead deals being the acquisition of Pharmasset and Myogen.

Abstracted from: Report: Partnering Agreements with Gilead Sciences 2005-2013

Gilead Sciences is involved in M&A activity for growth similar to its peers in the list of top pharmaceutical companies. Gilead Sciences has on occasions sought growth through strategic acquisition, for example when acquiring Pharmasset and CV Therapeutics.

The following figure shows the level of Gilead Sciences M&A deal announcements since 2005.

Figure 1: Gilead Sciences M&A deals 2005-2013

Gilead m and a per year

Source: Current Agreements, 2013

Gilead Sciences has signed 9 M&A deals since 2005. Companies acquired include:

  • Pharmasset
  • Myogen
  • CV Therapeutics
  • YM Biosciences

View the full list at Current Agreements (subscription required)

Gilead Sciences has been attracted to acquisition transactions whereby the company expands through the acquisition and assimilation of strategic target assets to realize business growth. This is evidenced by the acquisition of YM Biosciences to access the hematologic cancers business.

The following figure provides a summary of the top M&A deals by headline value.

Figure 2: Top Gilead Sciences M&A deals by headline value 2005-2013

Gilead m and a top deals by value

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal.

See: Partnering Agreements with Gilead Sciences 2005-2013

Gilead Sciences M&A at Current Agreements 

View all M&A deals for GlaxoSmithKline: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Agreements with Gilead Sciences 2005-2013

 

More

Summary profile data for Gilead Sciences

Partnering interests for Gilead Sciences

Partnering activity for Gilead Sciences

 

Available reports from Current Partnering

Report: Partnering Agreements with Gilead Sciences 2005-2013

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Gilead Sciences

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Gilead Sciences company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply